Chymotrypsin activity signals to intestinal epithelium by protease‐activated receptor‐dependent mechanisms

Archive ouverte

Guignard, Simon | Saifeddine, Mahmoud | Mihara, Koichiro | Motahhary, Majid | Savignac, Magali | Guiraud, Laura | Sagnat, David | Sebbag, Mireille | Khou, Sokchea | Rolland, Corinne | Edir, Anissa | Bournet, Barbara | Buscail, Louis | Buscail, Etienne | Alric, Laurent | Camare, Caroline | Ambli, Mouna | Vergnolle, Nathalie | Hollenberg, Morley | Deraison, Céline | Bonnart, Chrystelle

Edité par CCSD ; Wiley -

International audience. Abstract Background and Purpose Chymotrypsin is a pancreatic protease secreted into the lumen of the small intestine to digest food proteins. We hypothesized that chymotrypsin activity may be found close to epithelial cells and that chymotrypsin signals to them via protease‐activated receptors (PARs). We deciphered molecular pharmacological mechanisms and gene expression regulation for chymotrypsin signalling in intestinal epithelial cells. Experimental Approach The presence and activity of chymotrypsin were evaluated by Western blot and enzymatic activity tests in the luminal and mucosal compartments of murine and human gut samples. The ability of chymotrypsin to cleave the extracellular domain of PAR1 or PAR2 was assessed using cell lines expressing N‐terminally tagged receptors. The cleavage site of chymotrypsin on PAR1 and PAR2 was determined by HPLC–MS analysis. The chymotrypsin signalling mechanism was investigated in CMT93 intestinal epithelial cells by calcium mobilization assays and Western blot analyses of (ERK1/2) phosphorylation. The transcriptional consequences of chymotrypsin signalling were analysed on colonic organoids. Key Results We found that chymotrypsin was present and active in the vicinity of the colonic epithelium. Molecular pharmacological studies have shown that chymotrypsin cleaves both PAR1 and PAR2 receptors. Chymotrypsin activated calcium and ERK1/2 signalling pathways through PAR2, and this pathway promoted interleukin‐10 (IL‐10) up‐regulation in colonic organoids. In contrast, chymotrypsin disarmed PAR1, preventing further activation by its canonical agonist, thrombin. Conclusion and Implications Our results highlight the ability of chymotrypsin to signal to intestinal epithelial cells via PARs, which may have important physiological consequences in gut homeostasis.

Suggestions

Du même auteur

Increased mucosal thrombin is associated with Crohn's disease and causes inflammatory damage through Protease-Activated Receptors activation

Archive ouverte | Motta, Jean-Paul | CCSD

International audience. Background and Aims: Thrombin levels in the colon of Crohn’s disease patients have recently been found to be elevated 100-fold compared to healthy controls. Our aim was to determine whether a...

Epithelial production of elastase is increased in inflammatory bowel disease and causes mucosal inflammation

Archive ouverte | Motta, Jean-Paul | CCSD

International audience. Imbalance between proteases and their inhibitors plays a crucial role in the development of Inflammatory Bowel Diseases (IBD). Increased elastolytic activity is observed in the colon of patie...

Tools for proteases/anti-proteases profiling in the gut

Archive ouverte | Sagnat, David | CCSD

Poster P1002. International audience

Chargement des enrichissements...